Cycling Janus kinase inhibitors versus switching to biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis with inadequate Janus kinase inhibitor response: a systematic review and meta-analysis
Journal of Rheumatic Diseases · 04.05.2026
DOI: 10.4078/jrd.2026.0021 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Rheumatic Diseases, online erschienen am 04.05.2026. Verfasst von Young Ho Lee und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lee, Y. H., & Song, G. G. (2026). Cycling Janus kinase inhibitors versus switching to biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis with inadequate Janus kinase inhibitor response: a systematic review and meta-analysis. Journal of Rheumatic Diseases. https://doi.org/10.4078/jrd.2026.0021
Vancouver
Lee YH, Song GG. Cycling Janus kinase inhibitors versus switching to biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis with inadequate Janus kinase inhibitor response: a systematic review and meta-analysis. Journal of Rheumatic Diseases. 2026. doi:10.4078/jrd.2026.0021
BibTeX
@article{Lee2026,
author = {Lee, Young Ho and Song, Gwan Gyu},
title = {Cycling Janus kinase inhibitors versus switching to biological disease-modifying anti-rheumatic drugs in rheumatoid arthritis with inadequate Janus kinase inhibitor response: a systematic review and meta-analysis},
journal = {Journal of Rheumatic Diseases},
year = {2026},
doi = {10.4078/jrd.2026.0021}
}
EUVIMED